Publication
PGC1α-mediated upregulation of PHD2 represses HIF-signaling, limiting prostate cancer progression.
Maider Fagoaga-Eugui, Natalia Martin-Martin, Amaia Zabala-Letona, Oihana Iriondo, Ana Talamillo, Lorea Valcarcel-Jimenez, Encarnación Pérez-Andrés, Onintza Carlivaris, Saioa Garcia-Longarte, Ferran Medina-Jover, Alice Macchia, Francesc Viñals, Veronica Torrano, Arkaitz Carracedo, Edurne Berra
- Source
- PubMed
- Retrieved
- Sep 19, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260919-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
PPARγ coactivator 1 alpha (PGC1α) is a master transcriptional coregulator of metabolism, and its activity mirrors many of the effects of hypoxia signaling in prostate cancer (PCa). Whereas PGC1α restrains PCa progression through its association with the estrogen-related receptor alpha (ERRα) and is…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Prostate Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available